"Calcium Channels" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue.
| Descriptor ID |
D015220
|
| MeSH Number(s) |
D12.776.157.530.400.150 D12.776.543.550.450.150 D12.776.543.585.400.150
|
| Concept/Terms |
Calcium Channels- Calcium Channels
- Ion Channel, Calcium
- Calcium Ion Channel
- Ion Channels, Calcium
- Calcium Ion Channels
- Calcium Channel Blocker Receptor
- VDCC
- Receptors, Calcium Channel Blocker
- Calcium Channel Antagonist Receptors
- Receptors, Calcium Channel Antagonist
- Calcium Channel Antagonist Receptor
- Voltage-Dependent Calcium Channels
- Calcium Channels, Voltage-Dependent
- Channels, Voltage-Dependent Calcium
- Voltage Dependent Calcium Channels
- Calcium Channel
- Calcium Channel Blocker Receptors
|
Below are MeSH descriptors whose meaning is more general than "Calcium Channels".
Below are MeSH descriptors whose meaning is more specific than "Calcium Channels".
This graph shows the total number of publications written about "Calcium Channels" by people in this website by year, and whether "Calcium Channels" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 1 | 3 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 2 | 4 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 4 | 4 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 4 | 5 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 3 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcium Channels" by people in Profiles.
-
Fernández-Morales JC, Morad M. Regulation of Ca2+ signaling by acute hypoxia and acidosis in rat neonatal cardiomyocytes. J Mol Cell Cardiol. 2018 01; 114:58-71.
-
Moran RA, James T, Pasricha PJ. Pancreatic pain. Curr Opin Gastroenterol. 2015 Sep; 31(5):407-15.
-
Ilatovskaya DV, Palygin O, Levchenko V, Staruschenko A. Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli. J Vis Exp. 2015 Jun 27; (100):e52850.
-
Wilson PC, Fitzgibbon WR, Garrett SM, Jaffa AA, Luttrell LM, Brands MW, El-Shewy HM. Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. Mol Endocrinol. 2015 Jun; 29(6):896-908.
-
Spencer S, Brown RM, Quintero GC, Kupchik YM, Thomas CA, Reissner KJ, Kalivas PW. a2d-1 signaling in nucleus accumbens is necessary for cocaine-induced relapse. J Neurosci. 2014 Jun 18; 34(25):8605-11.
-
Schwartz J, Holmuhamedov E, Zhang X, Lovelace GL, Smith CD, Lemasters JJ. Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporter. Toxicol Appl Pharmacol. 2013 Nov 15; 273(1):172-9.
-
Saggu S, Cannon TD, Jentsch JD, Lavin A. Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice. Schizophr Res. 2013 May; 146(1-3):254-63.
-
Rosa AO, Yamaguchi N, Morad M. Mechanical regulation of native and the recombinant calcium channel. Cell Calcium. 2013 Apr; 53(4):264-74.
-
Nickel JC, Crossland A, Davis E, Haab F, Mills IW, Rovner E, Scholfield D, Crook T. Investigation of a Ca2+ channel a2d ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial. J Urol. 2012 Sep; 188(3):817-23.
-
Smith GS, De Avila M, Paez PM, Spreuer V, Wills MK, Jones N, Boggs JM, Harauz G. Proline substitutions and threonine pseudophosphorylation of the SH3 ligand of 18.5-kDa myelin basic protein decrease its affinity for the Fyn-SH3 domain and alter process development and protein localization in oligodendrocytes. J Neurosci Res. 2012 Jan; 90(1):28-47.